Patent Yard Sign in
Expired Canadian patentCanada

Method for purification of filamentous hemagglutinin

CA 1237998 A · Owner: Juridical Foundation The Chemo-Sero-Therapeutic · Inventors: Nishihara, Tsukasa; Tashiro, Tomitaka; Sakuma, Shin

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Abstract:, The invention provides an improved method for the purification of filamentous hemagglutinin (F-HA) on an industrial scale which comprises contacting a culture of a microorganism of the genus Bordetella with a cellulose sulfate gel, a polysaccharide gel chemically bound with dextran sulfate, or a crosslinked polysaccharide sulfate gel, thereby adsorbing the F-HA on the gel and then, eluting the F-HA from the gel. The method can give a highly purified F-HA which does not contain any other proteins, lipids, saccharides, etc. and undesirable endotoxins, and hence can be used for producing various reagents, medicines and pertussis vaccine.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted June 14, 1988. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended June 14, 2005.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledApril 12, 1985
GrantedJune 14, 1988
Term endedJune 14, 2005
Patent numberCA 1237998 A
Classification (IPC)C12P21/00 +2 more

Timeline

Timeline From CIPO dates

1986198819901992199419961998200020022004Application filedApril 12, 1985Patent grantedJune 14, 1988Term endedJune 14, 2005

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.